Releases
-
Vanderbilt Poll 2021: Approval drops for TN’s elected leaders and second Trump run, but Dems and Republicans find unity on education, redistricting
Support for Gov. Bill Lee is down among Tennessee voters, fueled in part by his controversial stances on vaccine and mask requirements during the COVID-19 pandemic, according to the latest statewide Vanderbilt Poll. Read MoreDec 16, 2021
-
Shane Callahan named chief information security officer
Shane Callahan, an experienced leader in technology and information security, has been named Vanderbilt University’s first chief information security officer. He will join the university on Jan. 4. Read MoreDec 15, 2021
-
Stephen Taylor receives NSF CAREER award to study gravitational waves from supermassive black holes
Stephen Taylor, assistant professor of physics and astronomy, has received a National Science Foundation Faculty Early Career Development Program award to further his efforts to probe ultra-low-frequency gravitational waves. Read MoreDec 14, 2021
-
Immune landscape in adrenal cancer
The profile of immune-related gene expression and tumor-infiltrating immune cells in adrenocortical cancer suggests targets for new treatment strategies. Read MoreDec 14, 2021
-
Research Snapshot: Producing green fuel, and more rapid determination of the biological consequences of gene editing
Vanderbilt researchers examine how to rapidly characterize the biological impact of genetic editing on bacteria for energy production, drug discovery and more. Est. reading time: 2.5 mins. Read MoreDec 13, 2021
-
Oral microbes and gastric cancer
Studies in three large population cohorts that include Asian, African American and European American people support a role for the oral microbiota — the collection of microbial species in the mouth — in gastric cancer development. Read MoreDec 13, 2021
-
“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19
Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19. Read MoreDec 10, 2021
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read MoreDec 10, 2021
-
Alumni Innovators: Cybersecurity startup ARMS Cyber wins competitive awards from US Air Force, JPMorgan Chase and VetsinTech
Startup fostered at Vanderbilt earns accolades as it reimagines cybersecurity. Winning these awards earned the team $750,000 from the U.S. Air Force and $25,000 with mentorship from JPMorgan Chase leadership. Read MoreDec 10, 2021
-
Wilson Fund continues extraordinary impact on Vanderbilt music library, students and scholars
The vision of one of Vanderbilt University’s most influential benefactors, David K. “Pat” Wilson, BA’41, and his family will bring transformational change to the Anne Potter Wilson Music Library, which provides unique resources and services to the Blair School of Music. Read MoreDec 10, 2021
-
WATCH: Former U.S. Senate Majority Leader Bill Frist leads discussion on finding compromise in Congress
Former Senate Majority Leader Dr. Bill Frist shared examples from his time in political office and gave advice on what could help current lawmakers work toward compromise in a recent panel discussion on effective lawmaking. Read MoreDec 10, 2021
-
Cell signaling targets in leukemia
Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments. Read MoreDec 9, 2021
-
Prostate cancer treatment regret
Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity. Read MoreDec 9, 2021
-
International study supports dupilumab for treatment of moderate-to-severe asthma in children
In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients. Read MoreDec 8, 2021
-
Welcoming new faculty: Chezare A. Warren
Professor Chezare Warren This fall, Vanderbilt Peabody College of education and human development is pleased to welcome Chezare A. Warren as associate professor of educational equity and inclusion in educational policy. Professor Warren’s appointment is in the Department of Leadership, Policy, and Organizations. Professor Warren is a scholar of… Read MoreDec 8, 2021
-
McLean elected as 2021 National Academy of Inventors Fellow
John McLean, Stevenson Professor of Chemistry and director of the Center for Innovative Technologies, has been elected a 2021 fellow of the National Academy of Inventors. Read MoreDec 8, 2021
-
A potential new approach for the treatment of schizophrenia
Researchers discover how a protein may treat schizophrenia, including reversing working memory deficits, a hallmark of schizophrenia for which there is currently no treatment. Read MoreDec 8, 2021
-
Primed for Change: As nursing faces dramatic transformation, a new dean takes charge at Vanderbilt
For many people, hospitals are uncomfortable places where reminders of illness and injury are at every turn. But for Pamela R. Jeffries, visits to a large hospital in Indianapolis as a teenager were fascinating, even inspiring, experiences. Read MoreDec 6, 2021
-
Ask An Expert: What is multisystem inflammatory syndrome in children (MIS-C) and what are the symptoms?
Dr. Sophie Katz, assistant professor of pediatric infectious diseases and associate medical director of the Pediatric Antimicrobial Stewardship Program, describes the symptoms and treatment of multisystem inflammatory syndrome in children (MIS-C). Read MoreDec 6, 2021
-
Ask an Expert: What do we know about the omicron variant?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read MoreDec 3, 2021